In a fluorescence imaging study, the IRDye800CW (Ex/Em: 774/789 nm) labeled therapeutic antibody, panitumumab-IRDye800, bound to EGFR positive rat glioma cells with higher affinity than the fluorescent EGFR ligand, EGF8008. The gene discussed is EGFR; the disease is central nervous system cancer.